Answers are grounded in this paper and cite their sources.
A high performance liquid chromatographic assay for piroxicam in pharmaceutical preparations is described. The method uses a reversed-phase C18 column with pH 3 aqueous buffer/methanol, 55:45, v/v mobile phase, and is selective for piroxicam in the presence of other "oxicams," synthetic precursors, by-products, degradation products, metabolites, and related compounds. Applications to capsules, tablets, ointments, suppositories, ophthalmic suspensions, and rodent feeds are cited.
No takes yet. Share an insight, caveat, or question.
Richards et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: